 |
|
|
| Poster session: Chronic Lymphocytic Leukemia - treatment |
| Date: | Saturday, 8 June 2002 |
| Time: | 17:15-18:45 |
| Room: | |
| 17:15-18:45 |
0821 |
|
|
EFFICIENCY AND TOXICITY OF THE FLUDARABINE AND CYCLOPHOSPHAMIDE COMBINED THERAPY IN RELAPSED/RESISTANT PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA - POLISH MULTICENTER STUDY
M. Kowal, M. Kowal, A. Dmoszynska, D. Jawniak, K. Lewandowski, J. Wegrzyn, D. Wolowiec, J. Piszcz, K. Roznowski (Lublin, Poland)
| 17:15-18:45 |
0822 |
|
|
RE-TREATMENT WITH CLADRIBINE-BASED REGIMENS IN RELAPSED B-CLL CHRONIC LYMPHOCYTIC LEUKEMIA
T. Robak, J.Z. Blonski, M. Kasznicki, J. Gora-Tybor, A. Hellmann, L. Konopka, A. Dmoszynska, J. Dwilewicz-Trojaczek, D. Wolowiec (Lodz, Poland)
| 17:15-18:45 |
0823 |
|
|
IMMUNOLOGICAL PROFILE IN CHRONIC LYMPHOCYTIC LEUEKMIA TREATED WITH CLADRIBINE OR CHLORAMBUCIL
J.Z. Blonski, M. Najder, M. Kasznicki, T. Robak (Lodz, Poland)
| 17:15-18:45 |
0824 |
|
|
CLADRIBINE COMBINED WITH CYCLOPHOSPHAMIDE IS HIGHLY EFFECTIVE IN THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA
T. Robak, J.Z. Blonski, M. Kasznicki, J. Gora-Tybor, J. Dwilewicz-Trojaczek, B. Stella-Holowiecka, D. Wolowiec (Lodz, Poland)
| 17:15-18:45 |
0825 |
|
|
SEQUENTIAL FLUDARABINE AND RITUXIMAB THERAPY IMPROVES OUTCOME IN B-CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)
G. Del Poeta, M.I. Del Principe, L. Maurillo, A. Venditti, F. Buccisano, A. Tamburini, G. Suppo, G. Suppo, C. Mazzone, C. Mazzone, A. Tendas, R. Marini, M. Irno Consalvo, M. Masi, S. Amadori (Rome, Italy)
| 17:15-18:45 |
0826 |
|
|
GENE EXPRESSION PROFILE IN INDOLENT COMPARED TO AGGRESSIVE CHRONIC LYMPHOCYTIC LEUKAEMIA
S. Fagerström, B. Olsson, M. Järnås, S. Jacobsson, B. Swolin, B. Carlsson, L. Carlsson, H. Wadenvik (Gothenburg, Sweden)
| 17:15-18:45 |
0827 |
|
|
"STANDARD DOSE"; RITUXIMAB IN REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
F. Rossini, S. Capalbo, M. Fumagalli, C. Battista, G. De Santis, S. Bolis, R. Montesano, V. Liso, E.M. Pogliani (Monza, Italy)
| 17:15-18:45 |
0828 |
|
|
SUSCEPTIBILITY OF FRESHLY ISOLATED B-NHL AND B-CLL TO RITUXIMAB INDUCED CELLULAR AND COMPLEMENT DEPENDENT LYSIS IN VITRO
M. Introna, R. Gramigna, V. Facchinetti, R. Broady, G.M. Borleri, T. Barbui, A. Rambaldi, J. Golay (Milano, Italy)
| 17:15-18:45 |
0829 |
|
|
CONSOLIDATION WITH CAMPATH-1H IN CHRONIC LYMPHOCYTIC LEUKEMIA RESPONDING TO FLUDARABINE IS SAFE AND EFFECTIVE
M. Montillo, A. M. Cafro, A. Tedeschi, B. Brando, P. G. Oreste, S. Veronese, R. Cairoli, E. Pungolino, E. Morra (Milano, Italy)
| 17:15-18:45 |
0830 |
|
|
Fludarabine and cyclophosphamide combination in patients with relapsed/refractory chronic lymphocytic leukaemia and indolent non-Hodgkin's lymphoma: An evaluation of efficacy and toxicity
L.M. Laptalo, P.M. Lara, R.T. O'Donnell, I.L. Lauder, T. Wun, J. Tuscano (Sacramento, United States of America)
| 17:15-18:45 |
0831 |
|
|
High dose chlorambucil versus CHOP in patients with advanced B-chronic lymphocytic leukemia (B-CLL)
J.T. tasa Tasic (Nis, Yugoslavia)
| 17:15-18:45 |
0832 |
|
|
ALLOGENEIC STEM CELL TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA USING INTENSITY-REDUCED CONDITIONING: AN EBMT SURVEY
P. Dreger, R. Brand, P. Corradini, J. Finke, J. Hansz, G. Lambertenghi Deliliers, R. Martino, N. Russell, M. Michallet, D. Niederwieser (Hamburg, Germany)
| 17:15-18:45 |
0833 |
|
|
SEVERE HEMATOLOGICAL AND NON-HEMATOLOGICAL TOXICITY BUT GOOD EFFICACY OF BENDAMUSTINE (B) IN PRETREATED PATIENTS WITH CLL-RESULTS OF A PHASE I STUDY OF THE GERMAN CLL STUDY GROUP (GCLLSG)
M.B. Bergmann, B. Schmitt, C.M. Wendtner, B. Emmerich, M. Herold, M. Wilhelm, L. Böning, M. Hallek (München, Germany)
|